Pharma Foods keeps year-end profit target after nine-month loss deepens
Pharma Foods kept its year-end profit target unchanged even after a much uglier nine months. Cumulative sales rose 3.7% to JPY 48,555m, but operating loss widened to JPY 1,430m, the equity ratio fell to 28.9% from 35.4%, and interest-bearing debt rose to JPY 17,235m; management says the loss was built into an investment-heavy plan and still forecasts JPY 2,000m in full-year operating profit. That leaves the fourth quarter doing a great deal of narrative heavy lifting.